Cancer Treatment in India for Zimbabwean Patients

India is well suited to the multi-month, multi-visit nature of cancer care specifically because of its low per-cycle costs and established international-patient infrastructure. Apollo Proton Cancer Centre (Chennai) is the strongest vetted candidate found for oncology across all destinations researched — it's JCI- and NABH-accredited, houses South Asia's first proton therapy centre, and has a dedicated international patient team with independently corroborated patient flow from Kenya, Nigeria, Ghana, and Tanzania. No equivalent African-patient evidence exists yet for Turkey's or South Africa's candidate hospitals for this procedure.

South Africa is the closer option geographically for a Zimbabwean patient and has the region's only broad private oncology infrastructure — but its candidate hospital, Wits Donald Gordon Medical Centre, is the weakest-researched of the three: no confirmed accreditation, no visible international-patient department, and no published pricing. Given how long a cancer treatment course runs (often months, with repeat cycles), the strength of India's documented infrastructure and Africa-track-record makes it the better-supported starting point, even though it's the longer flight.

**In Zimbabwean terms:** India's Direct Medical range per chemotherapy cycle is roughly **$420 – $1,200**, and a full radiotherapy course is roughly **$1,800 – $3,600** — already stated in USD. Zimbabwe's own currency has had significant volatility and depreciation history in recent years; most medical travel budgeting by Zimbabwean patients is done directly in USD rather than ZWL/ZiG. Confirm current terms with your coordinator, especially given cancer treatment's multi-month duration.

Per India's "Heal in India" program (see `content-briefs/destinations/india.md`):

- **e-Medical Visa:** Online application, no embassy visit, valid 60 days, up to three entries. This is likely too short for a full multi-month cancer treatment course — the oncology procedure brief itself flags that **multi-month visa validity for treatments like this needs explicit per-destination checking**, and that has not been done for Zimbabwe. - **Regular (Paper) Medical Visa:** Required for extended chemotherapy or radiotherapy courses running months, per the destination brief. This is the more likely pathway for most cancer patients. - **Medical Attendant Visa:** Up to two blood relatives or legal guardians can accompany you. - **FRRO Registration:** Required if your stay (patient or attendant) exceeds 180 days — genuinely plausible for a multi-cycle chemotherapy course. - **Yellow Fever certificate:** Named explicitly for Nigeria/Ghana travelers in the India destination brief; not confirmed for Zimbabwe, though it is a general WHO/IHR requirement for many African departure points. `[NEEDS VERIFICATION: whether India's Yellow Fever certificate requirement applies specifically to travelers departing from Zimbabwe]` - **Fees, processing time, multi-entry validity for a multi-month course:** none of this is confirmed for Zimbabwe specifically. `[NEEDS VERIFICATION: Zimbabwe-specific visa detail — including whether a multi-cycle chemotherapy/radiotherapy course requires the paper Medical Visa rather than the e-Visa — not yet researched by visa-logistics-researcher]`

Abilitreat's coordinators — Amara, Manoja, and Dominic, with more joining the team — work as a shared pool covering every market we serve. You'll be connected with a named, real coordinator via WhatsApp who follows your case from first contact through post-return follow-up at 30/90/180 days — not routed through a hospital's own sales-oriented international patient desk.

Your medical records go through AI-assisted clinical summarization with mandatory human/clinical review before being shared with any hospital, you receive three side-by-side quotes with costs and logistics laid out plainly, and Abilitreat's referral fee is disclosed to you upfront before you commit to any hospital.